Burleson & Company, LLC Amgen Inc Transaction History

Burleson & Company, LLC

$384 Million
Q4 2022

A detailed history of Burleson & Company, LLC transactions in Amgen Inc stock. As of the latest transaction made, Burleson & Company, LLC holds 1,953 shares of AMGN stock, worth $546,976. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,953

Previous 3,251 39.93%

Holding current value

$546,976

Previous $733,000 30.15%

% of portfolio

0.13%

Previous 0.16%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $297,280 - $377,730	-1,298 Reduced 39.93%	1,953 $512,000
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $448 - $506	-2 Reduced 0.06%	3,251 $733,000
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $1,614 - $1,797	7 Added 0.22%	3,253 $792,000
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $8,770 - $9,702	-40 Reduced 1.22%	3,246 $785,000
Q4 2021 Jan 25, 2022	BUY	$198.88 - $227.6 $397 - $455	2 Added 0.06%	3,286 $739,000
Q3 2021 Nov 02, 2021	SELL	$212.27 - $248.7 $636 - $746	-3 Reduced 0.09%	3,284 $698,000
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $10,511 - $11,661	45 Added 1.39%	3,287 $801,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $3.14 Million - $3.65 Million	-14,130 Reduced 81.34%	3,242 $807,000
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $1.61 Million - $1.92 Million	-7,436 Reduced 29.97%	17,372 $3.99 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $1.85 Million - $2.05 Million	-7,869 Reduced 24.08%	24,808 $5.75 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $849,198 - $1.04 Million	4,293 Added 15.12%	32,677 $7.87 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $714,927 - $948,189	3,923 Added 16.04%	28,384 $6.67 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $58,844 - $75,635	-311 Reduced 1.26%	24,461 $5.79 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $40,741 - $48,817	234 Added 0.95%	24,772 $5.04 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $1.43 Million - $1.68 Million	8,582 Added 53.79%	24,538 $4.56 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $1.74 Million - $1.96 Million	9,597 Added 150.92%	15,956 $2.83 Million
Q4 2018 Feb 27, 2019	BUY	$178.4 - $208.25 $828,668 - $967,321	4,645 Added 271.0%	6,359 $1.18 Million
Q3 2018 Dec 06, 2018	BUY	$185.29 - $208.89 $317,587 - $358,037	1,714 New	1,714 $334,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.

Account

Burleson & Company, LLC Amgen Inc Transaction History